全文获取类型
收费全文 | 85659篇 |
免费 | 7495篇 |
国内免费 | 4075篇 |
专业分类
耳鼻咽喉 | 1004篇 |
儿科学 | 1021篇 |
妇产科学 | 1443篇 |
基础医学 | 12059篇 |
口腔科学 | 1963篇 |
临床医学 | 9035篇 |
内科学 | 14845篇 |
皮肤病学 | 1335篇 |
神经病学 | 5717篇 |
特种医学 | 2936篇 |
外国民族医学 | 30篇 |
外科学 | 10370篇 |
综合类 | 10291篇 |
现状与发展 | 12篇 |
一般理论 | 5篇 |
预防医学 | 5036篇 |
眼科学 | 2441篇 |
药学 | 8096篇 |
26篇 | |
中国医学 | 2613篇 |
肿瘤学 | 6951篇 |
出版年
2024年 | 134篇 |
2023年 | 865篇 |
2022年 | 1892篇 |
2021年 | 2356篇 |
2020年 | 1750篇 |
2019年 | 1814篇 |
2018年 | 2338篇 |
2017年 | 2028篇 |
2016年 | 1858篇 |
2015年 | 2512篇 |
2014年 | 3188篇 |
2013年 | 3229篇 |
2012年 | 4730篇 |
2011年 | 4772篇 |
2010年 | 2842篇 |
2009年 | 2521篇 |
2008年 | 3381篇 |
2007年 | 3574篇 |
2006年 | 3466篇 |
2005年 | 3174篇 |
2004年 | 2392篇 |
2003年 | 2324篇 |
2002年 | 2134篇 |
2001年 | 5337篇 |
2000年 | 5281篇 |
1999年 | 4783篇 |
1998年 | 1936篇 |
1997年 | 1644篇 |
1996年 | 1095篇 |
1995年 | 903篇 |
1994年 | 797篇 |
1993年 | 609篇 |
1992年 | 2183篇 |
1991年 | 1893篇 |
1990年 | 1707篇 |
1989年 | 1644篇 |
1988年 | 1438篇 |
1987年 | 1296篇 |
1986年 | 1146篇 |
1985年 | 964篇 |
1984年 | 617篇 |
1983年 | 482篇 |
1982年 | 270篇 |
1981年 | 195篇 |
1980年 | 149篇 |
1979年 | 286篇 |
1978年 | 77篇 |
1974年 | 75篇 |
1973年 | 95篇 |
1972年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
L.‐Q. Zheng X.‐C. Han Y. Huang H.‐W. Li X.‐D. Niu J. Li 《Clinical and experimental dermatology》2015,40(3):293-297
Porocarcinoma is an unusual, locally aggressive and potentially fatal neoplasm. Several cutaneous malignancies have been described in association with porocarcinoma, including squamous cell carcinoma, basal cell carcinoma and tricholemmal carcinoma. Previous reports have indicated that the occurrence of malignant tumours in combination with porocarcinoma is extremely rare, in particular with regard to Bowen disease (BD). We report an uncommon case of porocarcinoma occurring synchronously in a single BD lesion in a 63‐year‐old woman with multiple BD lesions. The clinical and histological findings confirmed this diagnosis. 相似文献
12.
13.
14.
目的探讨1 470 nm激光剜除治疗高危前列腺增生的手术技巧及临床效果。
方法回顾分析2018年6月至2018年9月中山大学附属第三医院泌尿外科采用1 470 nm激光治疗共89例高危前列腺增生患者的临床资料,年龄平均(68±3)岁,前列腺体积(57.4±2.6)ml。所有患者均采用"寻找层面,先易后难,剜切结合"的层面递进法思路行激光腔内前列腺剜除术,比较患者术中及术后情况。
结果89例均顺利完成手术,与术前相比,术后3个月患者最大尿流率明显增加,[(6.9±2.1) ml/s vs(19.8±3.6) ml/s]。国际前列腺症状评分显著好转,[(24.6±1.7) vs(8.0±1.2)]。术中无输血、无电切综合征、无直肠和膀胱穿孔病例,无输尿管损伤、大出血、心脑血管意外等严重并发症发生。
结论层面递进法激光剜除技术构想对于高危前列腺增生外科包膜层面的寻找、减少术后并发症有独到优势,且易于掌握,或可为业界同行提供一个新的思路。 相似文献
15.
16.
Widely Metastatic Squamous Cell Carcinoma Originating from Malignant Transformation of Hypertrophic Lichen Planus in a 24‐Year‐Old Woman: Case Report and Review of the Literature
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lana X. Tong B.A. Matthew J. Weinstock M.D. Reed Drews M.D. Caroline C. Kim M.D. 《Pediatric dermatology》2015,32(3):e98-e101
Hypertrophic lichen planus (HLP) is a T‐cell‐mediated process typically presenting with hypertrophic or verrucous plaques on the lower limbs. We report the case of a 24‐year‐old woman with a history of HLP since age 3 years presenting with rapid malignant transformation of one lesion into a large squamous cell carcinoma (SCC). Subsequent examination revealed progressive, widespread metastatic involvement, and the patient ultimately died from her disease. SCC associated with HLP is rare, with a review of the literature revealing fewer than 50 cases. This case highlights the need to be aware of suspicious changes in HLP and to educate patients as to when to be reevaluated. 相似文献
17.
18.
19.
Qianlai Luo Jonathan N. Hofmann Ruth M. Pfeiffer Cari M. Kitahara Minkyo Song Meredith S. Shiels 《International journal of cancer. Journal international du cancer》2023,153(1):64-72
In the United States, renal cell carcinoma (RCC) incidence and the prevalence of obesity, an established risk factor for RCC, have been increasing for several decades. RCC is more common among older individuals. We sought to quantify the contribution of excess adiposity to the rising incidence of RCC among individuals 60 years or older. National Institutes of Health-American Association of Retired Persons Diet and Health Study data (n = 453 859 participants, enrolled in 1995-1996, age at enrollment 50-71 years) were used to estimate multivariable-adjusted hazard ratios (HRs) for RCC across body mass index categories and HRs associated with smoking. Population attributable fractions (PAFs) were calculated using estimated HRs and annual overweight/obesity prevalence from the National Health Interview Survey (1985-2008). PAF estimates were combined with RCC incidence from Surveillance, Epidemiology and End Results-13 to calculate annual percent changes in RCC incidence attributable (and unrelated) to overweight/obesity. We found that between 1995 and 2018, among individuals aged 60 years and older, PAF for overweight/obesity increased from 18% to 29% for all RCCs. In comparison, the PAF for smoking declined from 12% to 9%. RCC incidence increased 1.8% per year (95% confidence interval [CI] 1.5%-2.1%) overall, while RCC incidence attributable to overweight/obesity increased 3.8% per year (95%CI 3.5%-4.2%) and RCC incidence unrelated to overweight/obesity increased 1.2% per year (95% CI 0.9%-1.4%). In conclusion, overweight/obesity appears to have contributed importantly to the rising incidence of RCC in the United States since the mid-1990s. Public health interventions focused on reducing overweight and obesity could help substantially in curbing this trend. 相似文献